Retail Cannabis Sales Fuel 506% Revenue Growth for HEXO Corp. in Q1

Gross revenue for the quarter reached $6.7 million, which includes $5.2 million in sales of adult-use cannabis in the first two weeks following legalization in Canada.

Read more
Tilray® Signs Letter of Intent for Hemp-Derived CBD from the U.S. and Canada

Tilray, Inc. (NASDAQ:TLRY), a global leader in cannabis research and production, today announced the terms of a binding letter of intent (“LOI”) to purchase hemp-derived CBD isolate from LiveWell Canada Inc. (CSE:LVWL), which will be sourced from the United States and Canada and utilized for distribution of Tilray-owned wellness and medical products across North America.

Read more
Namaste Enters Agreement with Pineapple Express

Namaste Technologies Inc.(TSXV: N) (FRANKFURT: M5BQ) (OTCMKTS: NXTTF) is pleased to announce that the Company has entered into a share purchase agreement to acquire common shares in Pineapple Express Delivery Inc. and an affiliated entity, representing an additional 34% equity in exchange for such number of common shares of Namaste having an aggregate value of approximately $3.06 Million. Upon completion of the Transaction, Namaste will own 49% of the outstanding common shares of Pineapple Express.

Read more
New York Governor Announces Push To Legalize Marijuana, But There’s A Catch

New York state is going to legalize marijuana in 2019, but there’s a catch.

Read more

Read more

Read more

Read more

Read more

Read more

Tilray® Signs Global Collaboration Agreement with Leading Pharmaceutical Company

Tilray Canada Ltd., a subsidiary of Tilray Inc. (NASDAQ: TLRY), a global pioneer in the production, research, and distribution of medical cannabis, announced today that it entered into a global framework agreement to collaborate with Sandoz AG, a global leader in generic pharmaceuticals and biosimilars and a part of Novartis group, to increase availability of high quality medical cannabis products across the world.

Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )